“TOCILIZUMAB AS MONOCLONAL ANTIBODY THERAPY IN OVERCOMING ACUTE RESPIRATORY DISTRESS SYNDROME IN COVID-19 PATIENTS”. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, vol. 9, no. 3, Apr. 2022, pp. 92-101, https://doi.org/10.53366/jimki.v9i3.488.